Evidence check: APOE in the context of sleep

The question of APOE in the context of sleep is scientifically relevant, but the provided contexts contain no direct information on this topic. APOE, particularly the ε4 allele, is best known for its association with increased Alzheimer's risk. However, there is growing evidence from observational studies that ε4 carriers may experience more sleep disturbances, fragmented sleep, and altered circadian rhythms. Mechanistically, it is hypothesized that APOE4 impairs amyloid-beta clearance in the brain, which in turn may negatively affect sleep. However, the evidence base is not strong enough for clinical recommendations. Many studies are associative, have small sample sizes, or do not adequately control for confounders such as age, cognition, or lifestyle. Therefore, a consumer DNA test for APOE provides only a weak indication, not a diagnosis. Sleep hygiene, stress management, and medical evaluation of sleep problems are far more important than knowing one's APOE status. The evidence is rated as 'human-moderate' because there are reproducible associations but no randomized controlled trials demonstrating a causal effect.